Skip to main content

Table 2 Association between LBW and Sociodemographic, obstetric and clinical characteristics of 631 pregnant women

From: Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region

Variable

LBW

OR

(95% CI)

p-value

AOR

(95% CI)

p-value

No

n (%)

Yes

n (%)

Age groups

 18–24

254 (92.0)

22 (8.0)

0.8 (0.30–2.0)

0.60

0.25 (0.06–1.04)

0.06

 25–29

171 (95.5)

8 (4.5)

0.4 (0.14–1.28)

0.13

0.20 (0.05–0.84)

0.03

 30–34

110 (95.7)

5 (4.3)

0.4 (0.12–1.39)

0.15

0.32 (0.09–1.19)

0.09

  ≥ 35

55 (90.2)

6 (9.8)

1

   

Marital status

 Unmarried

148 (94.3)

9 (5.7)

1.2 (0.56–2.55)

0.65

  

 Married

442 (93.2)

32 (6.8)

    

Education level

 No formal education

24 (96.0)

1 (4.0)

0.8 (0.04–12.82)

0.84

  

 Primary education

342 (93.4)

24 (6.6)

1.3 (0.16–9.87)

0.82

  

 Secondary education

206 (93.2)

15 (6.8)

1.3 (0.16–10.50)

0.80

  

 Tertiary education

18 (94.7)

1 (5.3)

1

   

Attendance to ANC

  < 4

206 (91.2)

20 (8.8)

1.7 (0.88–3.14)

0.12

1.33 (0.62–2.89)

0.46

  ≥ 4

384 (94.8)

21 (5.2)

1

   

FEFO use

 No

17 (94.4)

1 (5.6)

0.8 (0.11–6.49)

0.87

  

 Yes

573 (93.5)

40 (6.5)

1

   

Mebendazole use

 No

34 (97.1)

1 (2.9)

0.4 (0.06–3.06)

0.38

  

 Yes

556 (93.3)

40 (6.7)

1

   

Gravidity

 Primigravida

219 (90.1)

24 (9.9)

3.1 (1.22–7.63)

0.02

3.0 (0.88–10.04)

0.08

 Multigravida

204 (94.9)

11 (5.1)

1.5 (0.544–4.143)

0.43

1.07 (0.30–3.85)

0.92

 Secundigravida

167 (96.5)

6 (3.5)

1

   

Gestation age (weeks)

  ≤ 36

42 (72.4)

16 (27.6)

8.4 (4.14–16.88)

< 0.01

1.12 (0.06–0.25)

< 0.01

  ≥ 37

548 (95.6)

25 (4.4)

1

   

IPTp-SP doses taken

 0

12 (85.7)

2 (14.3)

1

   

 1

64 (91.4)

6 (8.6)

0.56 (0.10–3.31)

0.51

0.25 (0.04–1.56)

0.13

 2

155 (91.7)

14 (8.3)

0.54 (0.11–2.67)

0.45

0.32 (0.06–1.74)

0.19

  ≥ 3

359 (95.0)

19 (5.0)

0.32 (0.07–1.52)

0.15

0.17 (0.03–0.88)

0.04

Malaria by MRDT

 Positive

3 (75)

1 (25)

4.5 (0.50–48.1)

0.17

11.9 (1.07–132.2)

0.04

 Negative

587 (93.6)

40 (6.4)

1

   

Maternal anemia

 Non-anemia (≥11.0 g/dL

349 (93.3)

25 (6.7)

1

   

 Mild anemia (10–10.9 g/dL)

139 (95.9)

6 (4.1)

0.242–1.501

0.28

1.16 (0.11–12.6)

0.9

 Moderate anemia (7.0–9.9 g/dL)

94 (91.3)

9 (8.7)

0.603–2.960

0.48

0.51 (0.04–5.78)

0.58

 Severe anemia (< 7.0 g/dL)

8 (88.9)

1 (11.1)

0.21–14.510

0.61

1.01 (0.10–9.99)

0.995

Foetal anemia

 Yes

34 (91.9)

3 (8.1)

0.78 (0.23–2.64)

0.68

  

 No

556 (93.6)

38 (6.4)

1

   
  1. Adjusted for age, ANC, gravidity, gestation age, IPTp-Sp use, malaria infection and maternal anemia